David J. Whellan, MD, MHS, FACC, FAHA
Philadelphia, PA 19107
(215) 503-7420 fax
MD, Washington University School of Medicine
Master Health Science in Clinical Research, Duke University
Hospital of University of Pennsylvania (HUP)
Clinical Cardiology, Duke University Medical Center
Thomas Jefferson University Hospital
Expertise & Research Interests
Dr. Whellan is the Principal Investigator of Jefferson Regional Clinical Center for the NIH HF Network, one of 9 centers across the United States selected to participate in a series of novel heart failure clinical trials. In addition, he serves as the Associate Provost for Clinical Research at Thomas Jefferson University and Associate Dean for Clinical Research at Sidney Kimmel Medical College.
He has authored over 175 peer-reviewed articles, reviews, abstracts, and book chapters on cardiomyopathy; and is an associate editor for the Journal of the American College of Cardiology Heart Failure journal.
Most Recent Peer-Reviewed Publications
- Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study
- Effect of natriuretic peptide–guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: A randomized clinical trial
- Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency the IRONOUT HF randomized clinical trial
- A Novel Rehabilitation Intervention for Older Patients With Acute Decompensated Heart Failure: The REHAB-HF Pilot Study
- Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation
- Cognitive Outcomes After Coronary Artery Bypass Grafting
- Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction—Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial
- Cardiovascular Outcomes With Minute Ventilation–Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial
- Easy to Predict, Difficult to Prevent
- Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?
- Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale
- Inpatient management of heart failure: Are we shooting at the right target?
- Multinational and multiethnic variations in health-related quality of life in patients with chronic heart failure
- Socioeconomic and partner status in chronic heart failure: Relationship to exercise capacity, quality of life, and clinical outcomes
- Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke
- Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION)
- Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: A randomized clinical trial
- Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers
- Statins and Exercise Training Response in Heart Failure Patients: Insights From HF-ACTION
- Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012